Emily Cedarbaum1, Yifei Ma, Rebecca Scherzer, Jennifer C Price, Adaora A Adimora, Marcas Bamman, Mardge Cohen, Margaret A Fischl, Kunihiro Matsushita, Igho Ofotokun, Michael Plankey, Eric C Seaberg, Michael T Yin, Carl Grunfeld, Shant Vartanian, Anjali Sharma, Phyllis C Tien. 1. aDepartment of Medicine, University of California, San Francisco bMedical Service, Department of Veterans Affairs Medical Center, San Francisco, California cDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina dDepartment of Cell, Developmental, and Integrative Biology eDepartment of Medicine fDepartment of Neurology, University of Alabama, Birmingham, Alabama gDepartment of Medicine, Cook County Health and Hospitals System, Chicago, Illinois hDepartment of Medicine, University of Miami, Miami, Florida iDepartment of Epidemiology, Johns Hopkins University, Baltimore, Maryland jDepartment of Medicine, Emory University, Atlanta, Georgia kDepartment of Medicine, Georgetown University Medical Center, Washington, District of Columbia lDepartment of Medicine, Columbia University, New York, New York mDepartment of Surgery, University of California, San Francisco, San Francisco, California nDepartment of Medicine, Albert Einstein College of Medicine, The Bronx, New York, USA.
Abstract
OBJECTIVES: HIV and hepatitis C virus (HCV) have been associated with cardiovascular disease (CVD), but it is unclear whether HIV and HCV are also associated with peripheral artery disease (PAD). We examined the association of HIV, HCV, and traditional CVD risk factors with PAD in the Women's Interagency HIV Study, a multicenter US cohort. METHODS: In this cross-sectional study, ankle-brachial index was estimated using Doppler ultrasound and manual sphygmomanometer in 1899 participants aged more than 40 years with HIV/HCV coinfection, HCV or HIV monoinfection, or neither infection. Multivariable logistic regression was used to estimate the odds of PAD (ankle-brachial index ≤0.9) after controlling for demographic, behavioral, and CVD risk factors. RESULTS: Over two-thirds were African-American, median age was 50 years, and PAD prevalence was 7.7% with little difference by infection status. After multivariable adjustment, neither HIV nor HCV infection was associated with greater odds of PAD. Factors associated with PAD included older age [adjusted odds ratio (aOR): 2.01 for age 61-70 vs. 40-50 years; 95% confidence interval (CI): 1.04, 3.87], Black race (aOR: 2.30; 95% CI: 1.15, 4.63), smoking (aOR: 1.27 per 10-pack-year increment; 95% CI: 1.09, 1.48), and higher SBP (aOR: 1.14 per 10 mmHg; 95% CI: 1.01, 1.28). CONCLUSION: The high PAD prevalence in this nationally representative cohort of women with or at risk for HIV is on par with general population studies in individuals a decade older than our study's median age. HIV and HCV infection are not associated with greater PAD risk relative to uninfected women with similar risk factors. Modifiable traditional CVD risk factors may be important early intervention targets in women with and at risk for HIV.
OBJECTIVES: HIV and hepatitis C virus (HCV) have been associated with cardiovascular disease (CVD), but it is unclear whether HIV and HCV are also associated with peripheral artery disease (PAD). We examined the association of HIV, HCV, and traditional CVD risk factors with PAD in the Women's Interagency HIV Study, a multicenter US cohort. METHODS: In this cross-sectional study, ankle-brachial index was estimated using Doppler ultrasound and manual sphygmomanometer in 1899 participants aged more than 40 years with HIV/HCV coinfection, HCV or HIV monoinfection, or neither infection. Multivariable logistic regression was used to estimate the odds of PAD (ankle-brachial index ≤0.9) after controlling for demographic, behavioral, and CVD risk factors. RESULTS: Over two-thirds were African-American, median age was 50 years, and PAD prevalence was 7.7% with little difference by infection status. After multivariable adjustment, neither HIV nor HCV infection was associated with greater odds of PAD. Factors associated with PAD included older age [adjusted odds ratio (aOR): 2.01 for age 61-70 vs. 40-50 years; 95% confidence interval (CI): 1.04, 3.87], Black race (aOR: 2.30; 95% CI: 1.15, 4.63), smoking (aOR: 1.27 per 10-pack-year increment; 95% CI: 1.09, 1.48), and higher SBP (aOR: 1.14 per 10 mmHg; 95% CI: 1.01, 1.28). CONCLUSION: The high PAD prevalence in this nationally representative cohort of women with or at risk for HIV is on par with general population studies in individuals a decade older than our study's median age. HIV and HCV infection are not associated with greater PAD risk relative to uninfected women with similar risk factors. Modifiable traditional CVD risk factors may be important early intervention targets in women with and at risk for HIV.
Authors: Matthew A Allison; Elena Ho; Julie O Denenberg; Robert D Langer; Anne B Newman; Richard R Fabsitz; Michael H Criqui Journal: Am J Prev Med Date: 2007-04 Impact factor: 5.043
Authors: F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui Journal: Nat Rev Cardiol Date: 2016-11-17 Impact factor: 32.419
Authors: Sarah H Wild; Christopher D Byrne; Felicity B Smith; Amanda J Lee; F Gerald R Fowkes Journal: Diabetes Care Date: 2006-03 Impact factor: 19.112
Authors: Victor Aboyans; Robyn L McClelland; Matthew A Allison; Mary McGrae McDermott; Roger S Blumenthal; Katarzyna Macura; Michael H Criqui Journal: Atherosclerosis Date: 2010-10-21 Impact factor: 5.162
Authors: Birgitta Sigvant; Katarina Wiberg-Hedman; David Bergqvist; Olov Rolandsson; Bob Andersson; Elisabeth Persson; Eric Wahlberg Journal: J Vasc Surg Date: 2007-06 Impact factor: 4.268
Authors: Andrew L Callen; Sara M Dupont; Jeffrey Pyne; Jason Talbott; Phyllis Tien; Evan Calabrese; David Saloner; Felicia C Chow; Jared Narvid Journal: J Neurovirol Date: 2020-06-04 Impact factor: 2.643
Authors: Emily R Cedarbaum; Yifei Ma; Adaora A Adimora; Marcas Bamman; Mardge H Cohen; Margaret A Fischl; Deborah Gustafson; Kunihiro Matsushita; Igho Ofotokun; Michael Plankey; Eric C Seaberg; Anjali Sharma; Phyllis C Tien Journal: AIDS Date: 2022-03-01 Impact factor: 4.177
Authors: Natalie E Chichetto; Brittanny M Polanka; Kaku A So-Armah; Minhee Sung; Jesse C Stewart; John R Koethe; E Jennifer Edelman; Hilary A Tindle; Matthew S Freiberg Journal: Curr HIV/AIDS Rep Date: 2020-08 Impact factor: 5.495
Authors: Kaku So-Armah; Laura A Benjamin; Gerald S Bloomfield; Matthew J Feinstein; Priscilla Hsue; Benson Njuguna; Matthew S Freiberg Journal: Lancet HIV Date: 2020-04 Impact factor: 16.070